Dermatology-US

For US Healthcare Professional use only.
The safety and efficacy of these investigational agents have not been established.

Atopic Dermatitis

Long-term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate-to-severe Atopic Dermatitis Clinical Trials (RIVER-AD)

Long-term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate-to-severe Atopic Dermatitis Clinical Trials (RIVER-AD)

Long-term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate-to-severe Atopic Dermatitis Clinical Trials (RIVER-AD)

Scan and Download Back

Privacy & Data Protection Cookies Policy
Does not include study cards for clinical programs of dupilumab.

MAT-US-2401225 v1.0 - P Exp. Date: 02/12/2026
© 2024 Sanofi. All rights reserved.